Thomas Mckinley

Thomas Mckinley (board member) discloses dealings in Teladoc Health, Inc. to SEC (Form 4). In total, 23 filings cover trades dated from 5 July 2016 to 21 May 2025.

The open-market side counts 3 purchases for €103k alongside 3 sales for €8.7M. On balance, insiders were net sellers of €8.6M. Unlike grants, an open-market purchase is paid for by the insider, at the market price. The rest of the record consists of 13 option exercises.

Half of the purchases are above €28k and half below. On 1 out of 3 purchases, another insider of the same company was buying within the same 30 days. Purchases made close together by different insiders form what is called a cluster.

The newest entry dates from 23 May 2025: an option exercise, in Teladoc Health, Inc. The clock since the last published purchase (13 September 2024) now reads 771 days. The median gap between a trade and its publication by SEC (Form 4) is 2 days. The legal deadline for a Form 4 is two business days after the transaction. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.